Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 0093-1921

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 0093-1921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Image 1)

Structural Formula (Image 1)
FDA Label Image

Cyclobenzaprine Hydrochloride Extended-release Capsules 15 mg, 60s Label (Image 2)

Cyclobenzaprine Hydrochloride Extended-release Capsules 15 mg, 60s Label (Image 2)
FDA Label Image

Cyclobenzaprine Hydrochloride Extended-release Capsules 30 mg, 60s Label (Image 3)

Cyclobenzaprine Hydrochloride Extended-release Capsules 30 mg, 60s Label (Image 3)
FDA Label Image

Image 4

Image 4
FDA Label Image

Image 5

Image 5
FDA Label Image

Image 6

Image 6
FDA Label Image

Image 7

Image 7
FDA Label Image

Image 8

Image 8
This is a description of a medication packaging with the name Cyclobenzaprine Hydrochloride Extended-Release Capsules. The package contains 60 capsules. The provided information includes Lot/Exp Coding Area, NoC0093 192006, and the weight of the capsule. The text is not clear, and there is some garbage text.*
FDA Label Image

Image 9

Image 9
Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.